Shkreli’s scheme to boost drug price on display in Senate report

US senators have labeled “the hedge-fund model of drug pricing” employed by the likes of Turing Pharmaceuticals, formerly run by Martin Shkreli, as “predatory” and “immoral” in a newly released report on drug companies’ price hikes. The 131-page report – “Sudden Price Spikes in Off- Patent Prescription Drugs: The Monopoly Business Model that Harms Patients, Taxpayers, and the U.S.